Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure

European Heart Journal

Volumn 34, Issue 19, 2013, Pages 1414-1423

  Fröhlich, Georg M ^a,b   Keller, Philipp ^a   Schmid, Florian ^a   Wolfrum, Mathias ^a   Osranek, Martin ^a   Falk, Christian ^a   Noll, Georg ^a   Enseleit, Frank ^a   Reinthaler, Markus ^b   Meier, Pascal ^b   Lüscher, Thomas F ^a   Ruschitzka, Frank ^a   Tanner, Felix C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Heart failure; Mortality; Pericardial effusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; SPIRONOLACTONE;

ADULT; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RATE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LEUKOCYTE COUNT; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINUS RHYTHM; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TRICUSPID VALVE REGURGITATION;

HEART FAILURE; MORTALITY; PERICARDIAL EFFUSION;

CASE-CONTROL STUDIES; CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDITIS; PERICARDIAL EFFUSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84877944364     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht006     Document Type: Article

References (33)

1. Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J 2000;139:918-923.
2. Maisch B. Pericardial diseases, with a focus on etiology, pathogenesis, pathophysi-ology, new diagnostic imaging methods, and treatment. Curr Opin Cardiol 1994;9: 379-388.
3. Kessler KM, Rodriguez D, Rahim A, Dheen M, Samet P. Echocardiographic observations regarding pericardial-effusions associated with cardiac disease. Chest 1980; 78:736-740.
4. Ben-Horin S, Portnoy O, Pauzner R, Livneh A. Localized pericardial inflammation in systemic lupus erythematosus. Clin Exp Rheumatol 2004;22:483-484.
5. Wagner PL, McAleer E, Stillwell E, Bott M, Rusch VW, Schaffer W, Huang J. Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. J Thorac Cardiovasc Surg 2011;141:34-38.
6. Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526-1538.
7. Ashikhmina EA, Schaff HV, Sinak LJ, Li Z, Dearani JA, Suri RM, Park SJ, Orszulak TA, Sundt TM III. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg 2010; 89:112-118.
8. Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Chest 2011;140:1016-1024.
9. Hinderliter AL, Willis PWt, Long W, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Biosblanc B, Koch G, Li S, Clayton LM, Jobsis MM, Crow JW. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Pph study group. Primary pulmonary hypertension. Am J Cardiol 1999;84:481-484, A410.
10. Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci 2009;338:211-216.
11. Elliott Perry, Andersson Bert, Arbustini Eloisa, Bilinska Zofia, Cecchi Franco, Charron Philippe, Dubourg Olivier, Kühl Uwe, Maisch Bernhard, McKenna William J, Monserrat Lorenzo, Pankuweit Sabine, Rapezzi Claudio, Seferovic Petar, Tavazzi Luigi, Keren Andre. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270-276.
12. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocar-diography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713; quiz 786-688.
13. Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, Zamorano J, Nihoyannopoulos P. European association of echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 2008;9:438-448.
14. The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ACTS). Guidelines on the management of valvular heart disease (version 2012) (Eur J Echocardiography (2006) 7, 79e108). Eur Heart J 2012;33:2451-2496.
15. Lang Roberto M, Bierig Michelle, Devereux Richard B, Flachskampf Frank A, Foster Elyse, Pellikka Patricia A, Picard Michael H, Roman Mary J, Seward James, Shanewise Jack, Solomon Scott, Spencer Kirk T, John Sutton Martin St, Stewart William. Recommendations for chamber quantification. Eur J Echocardiography 2006;7:79e108.
16. Appleton CP, Hatle LK, Popp RL. Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardi-ography. J Am Coll Cardiol 1988;11:1020-1030.
17. Luchner A, Mockel M, Spanuth E, Mocks J, Peetz D, Baum H, Spes C, Wrede CE, Vollert J, Muller R, Katus H, Giannitsis E. N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (prompt): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial. Eur J Heart Fail 2012;14: 259-267.
18. Bayes-Genis A, de Antonio M, Galan A, Sanz H, Urrutia A, Cabanes R, Cano L, Gonzalez B, Diez C, Pascual T, Elosua R, Lupon J. Combined use of high-sensitivity st2 and ntprobnp to improve the prediction of death in heart failure. Eur J Heart Fail 2012;14:32-38.
19. Miller AJ, Pick R, Johnson PJ. The rates of formation of cardiac lymph and pericar-dial fluid after the production of myocardial venous congestion in dogs. Lymphol-ogy 1972;5:156-160.
20. Cui Y. The role of lymphatic vessels in the heart. Pathophysiology 2010;17: 307-314.
21. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (reveal). Circulation 2010;122:164-172.
22. Gan CT, McCann GP, Marcus JT, van Wolferen SA, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Nt-probnp reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 2006;28:1190-1194.
23. Hoeper MM, Barbera JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, Redfield MM, Robbins IM, Souza R, Torbicki A, McGoon M. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54:S85-S96.
24. Topilsky Y, Khanna A, Le Tourneau T, Park S, Michelena H, Suri R, Mahoney DW, Enriquez-Sarano M. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012;5:314-323.
25. Mitiku TY, Heidenreich PA. A small pericardial effusion is a marker of increased mortality. Am Heart J 2011;161:152-157.
26. Yu SB, Zhao QY, Huang H, Chen DE, Cui HY, Qin M, Huang CX. Prognosis investigation in patients with chronic heart failure and pericardial effusion. Chin Med J 2012;125:882-887.
27. Sugiura T, Kumon Y, Kataoka H, Matsumura Y, Takeuchi H, Doi Y. Asymptomatic pericardial effusion in patients with rheumatoid arthritis. Cardiology 2008;110: 87-91.
28. Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol 2011 ;34: 593-598.
29. Airaghi L, Montori D, Santambrogio L, Miadonna A, Tedeschi A. Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med 2000;247:731-735.
30. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev 2006;11:83-92.
31. Dixon DL, Griggs KM, Bersten AD, De Pasquale CG. Systemic inflammation and cell activation reflects morbidity in chronic heart failure. Cytokine 2011;56: 593-599.
32. Guder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, Ertl G, Angermann CE, Stork S. Reverse epidemiology in systolic and nonsystolic heart failure: Cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail 2009;2:563-571.
33. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.